OLMA Olema Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 10, 2026
$8,23
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$6,65rendah 52m
$36,26tinggi 52m
Kapitalisasi Pasar (MRQ)
$719M
P/E
-4.4
EPS
$-1.87
lencana Anda
Rentang 52M
$7–$36
Peringkat Analis
BUY
Target Harga
$36
P/E
-4.4
ROE
-39.4%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
OLMA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$8.22
Kapitalisasi Pasar (MRQ)
$719M
P/E
-4.4
EPS
$-1.87
ROE
-39.4%
Rentang 52M
$7–$36
OLMA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-1.872019-12-31 → 2025-12-31
Arus Kas Bebas·2021-12-31 → 2024-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | OLMA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -4.4rata-rata 5T ≈-5.7 | ≈-5.7 | · | · | |
| P/B (MRQ) | 1.7rata-rata 5T ≈2.0 | ≈2.0 | 3.5 | Kurang nilai | |
| Price / Cash Flow (Harga / Arus Kas) | -4.6rata-rata 5T ≈-7.2 | ≈-7.2 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 1.4rata-rata 5T ≈2.0 | ≈2.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | OLMA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -33.0%rata-rata 5T ≈-34.2% | ≈-34.2% | -33.0% | Sejajar | |
| ROE | -39.4%rata-rata 5T ≈-38.7% | ≈-38.7% | -39.4% | Sejajar | |
| ROIC | -37.3% | · | -68.5% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | OLMA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 8.9rata-rata 5T ≈15.5 | ≈15.5 | 8.4 | Sejajar | |
| Quick Ratio (Rasio Cepat) | 9.8rata-rata 5T ≈15.3 | ≈15.3 | 5.4 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.08%
Laporan Berikutnya
Nov 09, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 11, 2026 | $-0.61 | $-0.56 | -9.8% |
| 31 Maret 2026 | Mei 12, 2026 | $-0.52 | $-0.54 | 3.6% |
| 31 Des. 2025 | $-0.50 | $-0.54 | 7.3% | |
| 30 Sep. 2025 | $-0.49 | $-0.49 | 0.67% | |
| 30 Juni 2025 | $-0.51 | $-0.38 | -33.0% | |
| 31 Maret 2025 | $-0.36 | $-0.52 | 30.8% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $158M | $125M | $86M | $82M | $51M | $14M | |
| SG&A Expense | $21M | $18M | $19M | $25M | $20M | $8M | |
| Operating Expenses | $179M | $142M | $105M | $107M | $71M | $22M | |
| Operating Income | $-179M | $-142M | $-105M | $-107M | $-71M | $-22M | |
| Interest Expense | · | · | · | · | · | $653.0K | |
| Interest Income | $16M | $13M | $8M | $2M | $442.0K | $60.0K | |
| Other Non-op | $23.0K | $102.0K | $-19.0K | $-27.0K | $-47.0K | · | |
| Pretax Income | $-162M | $-129M | · | · | · | · | |
| Income Tax | $3.0K | $2.0K | $2.0K | $1.0K | · | · | |
| Net Income | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| EPS (Basic) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| EPS (Diluted) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| Shares (Basic) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| Shares (Diluted) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| EBITDA | $-178M | $-142M | $-105M | $-107M | $-71M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $139M | $69M | $24M | $14M | $339M | |
| Short-term Investments | $457M | $295M | $193M | $181M | $273M | · | |
| Prepaid Expense | $10M | $4M | $5M | $4M | $3M | $4M | |
| Current Assets | $515M | $438M | $267M | $209M | $291M | $342M | |
| PP&E (Net) | $274.0K | $746.0K | $968.0K | $1M | $1M | $75.0K | |
| PP&E (Gross) | · | · | · | $2M | $2M | $137.0K | |
| Accum. Depreciation | · | · | · | $581.0K | $224.0K | $62.0K | |
| Other Non-current Assets | · | $15.0K | · | $3M | $540.0K | $510.0K | |
| Total Assets | $533M | $451M | $277M | $216M | $296M | $343M | |
| Accounts Payable | $9M | $4M | $3M | $374.0K | $23.0K | $719.0K | |
| Current Liabilities | $52M | $42M | $22M | $17M | $9M | $5M | |
| Capital Leases | $69.0K | $257.0K | $1M | $2M | $2M | · | |
| Total Liabilities | $55M | $42M | $23M | $18M | $11M | $5M | |
| Common Stock | $8.0K | $7.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.08B | $844M | $559M | $408M | $389M | $371M | |
| Retained Earnings | $-598M | $-435M | $-306M | $-209M | $-104M | $-33M | |
| AOCI | $621.0K | $143.0K | $347.0K | $-2M | $-149.0K | · | |
| Stockholders' Equity | $479M | $409M | $254M | $198M | $285M | $338M | |
| Liabilities + Equity | $533M | $451M | $277M | $216M | $296M | $343M | |
| Shares Outstanding | 81,376,449 | 74,312,608 | 54,992,784 | 40,287,097 | 39,797,263 | 39,308,238 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $490.0K | $393.0K | $377.0K | $357.0K | $163.0K | $11.0K | |
| Stock-based Comp | $18M | $23M | $17M | $19M | $16M | $3M | |
| Other Non-cash | $-2M | $2M | $-5M | $4M | $4M | · | |
| Operating Cash Flow | $-147M | $-104M | $-84M | $-82M | $-51M | $-20M | |
| CapEx | · | $159.0K | · | $363.0K | $2M | $56.0K | |
| Investing Cash Flow | $-156M | $-94M | $-5M | $91M | $-275M | $-56.0K | |
| Financing Cash Flow | $211M | $269M | $133M | $476.0K | $1M | $358M | |
| Net Change in Cash | $-91M | $71M | $45M | $10M | $-325M | $338M | |
| Free Cash Flow | · | $-105M | · | $-82M | $-52M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -33.0% | -35.6% | -39.2% | -41.0% | -22.3% | · | |
| ROE | -39.4% | -42.6% | -36.5% | -50.5% | -24.3% | · | |
| ROIC | -37.3% | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 | · | |
| Quick Ratio | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.88 | $5.50 | $4.62 | $4.90 | $7.15 | · | |
| Cash Flow / Share | $-1.69 | $-1.78 | $-1.85 | $-2.05 | $-1.28 | · | |
| Cash / Share | $0.59 | $1.88 | $1.25 | $0.59 | $0.35 | · | |
| EPS (TTM) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| Market Cap | $2.03B | $433M | $772M | $99M | $373M | · | |
| P/E | -13.4 | -2.6 | -6.6 | -0.9 | -5.2 | -14.1 | |
| P/B | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Tangible Book | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Cash Flow | -13.9 | -4.2 | -9.2 | -1.2 | -7.3 | · | |
| P / FCF | · | -4.1 | · | -1.2 | -7.1 | · | |
| Earnings Yield | -7.5% | -37.7% | -15.2% | -106.9% | -19.2% | -7.1% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $58M | $49M | $43M | $40M | $44M | $31M | $32M | $33M | $29M | $30M | $26M | $19M | $18M | $23M | $22M | $18M | |
| SG&A Expense | $9M | $9M | $7M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $7M | $6M | $6M | |
| Operating Expenses | $67M | $58M | $50M | $46M | $48M | $35M | $37M | $38M | $34M | $34M | $30M | $23M | $22M | $30M | $27M | $23M | |
| Operating Income | $-67M | $-58M | $-50M | $-46M | $-48M | $-35M | $-37M | $-38M | $-34M | $-34M | $-30M | $-23M | $-22M | $-30M | $-27M | $-23M | |
| Interest Income | $5M | $5M | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $1M | $973.0K | $622.0K | |
| Other Non-op | $-528.0K | $121.0K | $13.0K | $12.0K | $38.0K | $-40.0K | $-93.0K | $138.0K | $40.0K | $17.0K | $93.0K | $-79.0K | $-44.0K | $11.0K | $67.0K | $-120.0K | |
| Net Income | $-63M | $-53M | $-46M | $-42M | $-44M | $-30M | $-34M | $-35M | $-30M | $-31M | $-27M | $-22M | $-20M | $-28M | $-26M | $-23M | |
| EPS (Basic) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| EPS (Diluted) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| Shares (Basic) | 104,453,732 | 102,800,098 | · | 85,732,221 | 85,497,426 | 85,426,223 | · | 57,262,803 | 56,282,402 | 55,574,324 | · | 44,977,161 | 40,720,294 | 40,354,493 | · | 40,036,201 | |
| Shares (Diluted) | 104,453,732 | 102,800,098 | · | 85,732,221 | 85,497,426 | 85,426,223 | · | 57,262,803 | 56,282,402 | 55,574,324 | · | 44,977,161 | 40,720,294 | 40,354,493 | · | 40,036,201 | |
| EBITDA | $-67M | $-58M | · | $-46M | $-48M | $-35M | · | $-38M | $-34M | $-34M | · | $-23M | $-22M | $-30M | · | $-23M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $53M | $48M | $35M | $52M | $51M | $139M | $36M | $17M | $34M | $69M | $117M | $35M | $41M | $24M | $27M | |
| Short-term Investments | $412M | $453M | $457M | $294M | $309M | $342M | $295M | $179M | $222M | $215M | $193M | $159M | $132M | $145M | $181M | $196M | |
| Prepaid Expense | $9M | $8M | $10M | $5M | $6M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $4M | $3M | $4M | $2M | |
| Current Assets | $470M | $513M | $515M | $334M | $368M | $397M | $438M | $218M | $242M | $252M | $267M | $282M | $172M | $189M | $209M | $225M | |
| PP&E (Net) | $382.0K | $356.0K | $274.0K | $486.0K | $560.0K | $653.0K | $746.0K | $849.0K | $945.0K | $1M | $968.0K | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $698.0K | $744.0K | $681.0K | · | $484.0K | |
| Other Non-current Assets | · | · | · | · | $15.0K | $14.0K | $15.0K | $15.0K | $16.0K | · | · | · | · | $3M | · | $3M | |
| Total Assets | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Accounts Payable | $2M | $4M | $9M | $3M | $934.0K | $151.0K | $4M | $3M | $4M | $8M | $3M | $2M | $2M | $681.0K | $374.0K | $14.0K | |
| Current Liabilities | $53M | $47M | $52M | $42M | $33M | $26M | $42M | $31M | $27M | $26M | $22M | $16M | $15M | $19M | $17M | $13M | |
| Capital Leases | $0 | $0 | $69.0K | $310.0K | $602.0K | $123.0K | $257.0K | $562.0K | $859.0K | $1M | $1M | $2M | $1M | $1M | $2M | $2M | |
| Total Liabilities | $56M | $50M | $55M | $45M | $37M | $26M | $42M | $31M | $27M | $27M | $23M | $18M | $16M | $21M | $18M | $14M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.15B | $1.13B | $1.08B | $858M | $854M | $849M | $844M | $600M | $594M | $573M | $559M | $554M | $419M | $413M | $408M | $403M | |
| Retained Earnings | $-714M | $-651M | $-598M | $-551M | $-509M | $-465M | $-435M | $-402M | $-367M | $-337M | $-306M | $-279M | $-257M | $-237M | $-209M | $-183M | |
| AOCI | $-947.0K | $-460.0K | $621.0K | $526.0K | $314.0K | $420.0K | $143.0K | $464.0K | $-118.0K | $-10.0K | $347.0K | $-241.0K | $-518.0K | $-978.0K | $-2M | $-3M | |
| Stockholders' Equity | $431M | $480M | $479M | $307M | $345M | $383M | $409M | $199M | $227M | $236M | $254M | $275M | $162M | $175M | $198M | $218M | |
| Liabilities + Equity | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Shares Outstanding | 87,452,166 | 87,332,971 | 81,376,449 | 68,652,730 | 68,627,886 | 68,333,065 | 74,312,608 | 57,288,319 | 57,246,411 | 55,867,863 | 54,992,784 | 54,601,516 | 41,122,482 | 40,438,320 | 40,287,097 | 40,084,568 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $102.0K | $119.0K | $187.0K | $43.0K | $132.0K | $128.0K | $116.0K | $95.0K | $94.0K | $88.0K | $88.0K | $90.0K | $99.0K | $100.0K | $97.0K | $91.0K | |
| Stock-based Comp | $13M | $10M | $4M | $4M | $5M | $4M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | $5M | $5M | $4M | |
| Other Non-cash | · | $-3M | · | · | · | $-18M | · | · | · | $2M | · | · | · | $3M | · | · | |
| Operating Cash Flow | $-46M | $-46M | $-38M | $-35M | $-30M | $-44M | $-26M | $-27M | $-28M | $-23M | $-18M | $-23M | $-22M | $-20M | $-20M | $-18M | |
| CapEx | · | · | · | $0 | · | · | $0 | $0 | $6.0K | $153.0K | · | · | · | · | $173.0K | $139.0K | |
| Investing Cash Flow | $41M | $5M | $-162M | $17M | $34M | $-45M | $-114M | $46M | $-5M | $-20M | $-31M | $-25M | $14M | $37M | $16M | $20M | |
| Financing Cash Flow | $1M | $46M | $214M | $41.0K | $-3M | $222.0K | $244M | $92.0K | $16M | $9M | $523.0K | $131M | $2M | $220.0K | $273.0K | $106.0K | |
| Net Change in Cash | $-4M | $4M | $13M | $-17M | $2M | $-89M | $104M | $19M | $-17M | $-35M | $-49M | $82M | $-6M | $17M | $-3M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-24M | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.5% | -11.3% | · | -14.5% | -13.8% | -9.0% | · | -13.2% | -14.1% | -13.5% | · | -8.2% | -9.4% | -12.0% | · | -8.4% | |
| ROE | -16.3% | -12.3% | · | -16.7% | -15.3% | -9.8% | · | -14.6% | -15.6% | -15.1% | · | -8.7% | -10.1% | -12.9% | · | -8.8% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 10.9 | · | 8.0 | 11.1 | 15.2 | · | 7.1 | 9.1 | 9.6 | · | 17.7 | 11.6 | 9.8 | · | 17.9 | |
| Quick Ratio | 8.7 | 10.7 | · | 7.9 | 10.9 | 15.1 | · | 7.0 | 9.0 | 9.5 | · | 17.3 | 11.3 | 9.6 | · | 17.7 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.92 | $5.50 | · | $4.48 | $5.03 | $5.61 | · | $3.47 | $3.97 | $4.23 | · | $5.04 | $3.93 | $4.33 | · | $5.43 | |
| Cash Flow / Share | · | $-0.45 | · | · | · | $-0.51 | · | · | · | $-0.42 | · | · | · | $-0.51 | · | · | |
| Cash / Share | $0.56 | $0.60 | · | $0.51 | $0.76 | $0.74 | · | $0.63 | $0.30 | $0.60 | · | $2.15 | $0.85 | $1.01 | · | $0.67 | |
| EPS (TTM) | $-2.13 | $-2.03 | · | $-1.86 | $-1.97 | $-2.00 | · | $-2.17 | $-2.05 | $-2.00 | · | $-2.32 | $-2.41 | $-2.74 | · | $-2.51 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-205M | $-185M | · | $-150M | $-142M | $-129M | · | $-123M | $-110M | $-99M | · | $-96M | $-97M | $-110M | · | $-100M | |
| Market Cap | $1.09B | $1.30B | · | $672M | $292M | $257M | · | $684M | $619M | $632M | · | $674M | $371M | $140M | · | $111M | |
| P/E | -5.9 | -7.3 | · | -5.3 | -2.2 | -1.9 | · | -5.5 | -5.3 | -5.7 | · | -5.3 | -3.7 | -1.3 | · | -1.1 | |
| P/B | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Tangible Book | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Cash Flow | · | -28.3 | · | · | · | -5.8 | · | · | · | -26.9 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -17.0% | -13.6% | · | -19.0% | -46.2% | -53.2% | · | -18.2% | -18.9% | -17.7% | · | -18.8% | -26.7% | -79.0% | · | -90.9% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-162M | $-129M | $-97M | $-105M | $-71M |
| EPS Dilusian | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 |
| Rasio Cepat | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | · | $-105M | · | $-82M | $-52M |
Pemilik institusional (13F) 199 pengaju · $1.4B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
199
Nilai yang dipegang
$1.4B
Posisi baru
25
Posisi yang keluar
37
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 25 (-33 vs Kuartal sebelumnya) | 37 (-10 vs Kuartal sebelumnya) | 72 (-4 vs Kuartal sebelumnya) | 68 (+15 vs Kuartal sebelumnya) | -8.9M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $151.909.702 | 12.143.062 | 11,15% | Saham |
| Paradigm Biocapital Advisors LP | $108.468.906 | 8.670.576 | 7,96% | Saham |
| JANUS HENDERSON GROUP PLC | $106.013.431 | 7.108.488 | 7,78% | Saham |
| VANGUARD GROUP INC | $89.033.875 | 3.561.355 | 6,53% | Saham |
| Bain Capital Life Sciences Investors, LLC | $88.636.465 | 7.085.249 | 6,50% | Saham |
| BlackRock, Inc. | $84.000.783 | 6.714.691 | 6,16% | Saham |
| BVF INC/IL | $66.251.621 | 5.295.893 | 4,86% | Saham |
| Siren, L.L.C. | $60.760.432 | 4.856.949 | 4,46% | Saham |
| STATE STREET CORP | $53.993.886 | 4.316.058 | 3,96% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $41.798.625 | 3.341.217 | 3,07% | Saham |
| Logos Global Management LP | $40.143.026 | 3.208.875 | 2,95% | Saham |
| FRANKLIN RESOURCES INC | $29.393.321 | 2.349.586 | 2,16% | Saham |
| Cormorant Asset Management, LP | $26.896.500 | 2.150.000 | 1,97% | Saham |
| MORGAN STANLEY | $22.921.685 | 1.832.269 | 1,68% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $22.759.853 | 1.819.029 | 1,67% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.806.857 | 1.663.218 | 1,53% | Saham |
| GOLDMAN SACHS GROUP INC | $19.615.417 | 1.567.979 | 1,44% | Saham |
| Deep Track Capital, LP | $18.765.000 | 1.500.000 | 1,38% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $17.718.405 | 1.416.533 | 1,30% | Saham |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | $16.954.790 | 1.355.299 | 1,24% | Saham |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $15.012.000 | 1.200.000 | 1,10% | Saham |
| TWO SIGMA INVESTMENTS, LP | $14.154.239 | 1.131.434 | 1,04% | Saham |
| Point72 Asset Management, L.P. | $13.397.572 | 1.070.949 | 0,98% | Saham |
| Defilade Capital Management, L.P. | $11.568.723 | 924.758 | 0,85% | Saham |
| AMERIPRISE FINANCIAL INC | $10.516.481 | 840.646 | 0,77% | Saham |
| Woodline Partners LP | $9.395.385 | 751.030 | 0,69% | Saham |
| Candriam S.C.A. | $9.387.633 | 751.133 | 0,69% | Saham |
| NORTHERN TRUST CORP | $8.443.561 | 674.945 | 0,62% | Saham |
| Vivo Capital, LLC | $8.404.756 | 671.843 | 0,62% | Saham |
| Qube Research & Technologies Ltd | $8.298.121 | 663.319 | 0,61% | Saham |
| CITADEL ADVISORS LLC | $8.029.268 | 641.828 | 0,59% | Saham |
| Squarepoint Ops LLC | $7.699.530 | 615.470 | 0,56% | Saham |
| READYSTATE ASSET MANAGEMENT LP | $7.428.801 | 593.829 | 0,55% | Saham |
| Jones Hill Capital LP | $7.182.817 | 574.166 | 0,53% | Saham |
| Hudson Bay Capital Management LP | $7.085.664 | 566.400 | 0,52% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $6.585.839 | 526.446 | 0,48% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6.484.458 | 518.342 | 0,48% | Saham |
| Vestal Point Capital, LP | $5.236.073 | 418.551 | 0,38% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $5.192.338 | 415.055 | 0,38% | Saham |
| Ikarian Capital, LLC | $4.794.845 | 383.281 | 0,35% | Saham |
| SEB Asset Management AB | $4.246.649 | 339.461 | 0,31% | Saham |
| BANK OF AMERICA CORP /DE/ | $4.189.287 | 334.875 | 0,31% | Saham |
| Fisher Asset Management, LLC | $3.712.015 | 296.724 | 0,27% | Saham |
| Rock Springs Capital Management LP | $2.942.077 | 235.178 | 0,22% | Saham |
| UBS Group AG | $2.788.141 | 222.873 | 0,20% | Saham |
| Bank of New York Mellon Corp | $2.779.441 | 222.177 | 0,20% | Saham |
| Pier Capital, LLC | $2.760.944 | 220.699 | 0,20% | Saham |
| Ikarian Capital, LLC | $2.502.000 | 200.000 | 0,18% | Opsi beli |
| Birchview Capital, LP | $2.489.490 | 199.000 | 0,18% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.280.573 | 182.300 | 0,17% | Opsi jual |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities GP LLC, Logos GP LLC ×4 pengajuan | 13 Mei 2025 | 4,70% | Amandemen | Investasi pasif | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×4 pengajuan | 4 Des. 2024 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 22 orang dalam · 10 pejabat · 12 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Sean Bohen | PRESIDENT AND CEO | 2 Feb. 2026 A | 237.650 | 0 | 0 | $0 |
| Jason O'Byrne | CHIEF FINANCIAL OFFICER | 1 Sep. 2026 A | · | 0 | 0 | $0 |
| Shawnte Mitchell | CHIEF LEGAL OFFICER | 4 Maret 2026 M | 0 | 0 | 3 | $-951.503 |
| Sasha Lu Austin | VP of Finance and Controller | 2 Feb. 2026 A | 16.188 | 0 | 0 | $0 |
| Naseem Zojwalla | CHIEF MEDICAL OFFICER | 2 Feb. 2026 A | 4.488 | 0 | 4 | $-7.530.148 |
| David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | 2 Feb. 2026 A | 542.761 | 0 | 8 | $-4.660.773 |
| Shane William Charles Kovacs | CH. OPERATING & FINANCIAL OFF. | 15 Jan. 2026 S | 139.727 | 0 | 2 | $-2.980.054 |
| Kinney Horn | Chief Business Officer | 1 Feb. 2023 A | 2.458 | 0 | 0 | $0 |
| John B Moriarty | EVP, Ch. Legal Officer & Sec. | 1 Feb. 2023 A | · | 0 | 0 | $0 |
| Peter J. Kushner | CHIEF SCIENTIFIC OFFICER | 1 Feb. 2022 A | 1.431.672 | 0 | 0 | $0 |
| Cyrus Harmon | Direktur | 24 Juli 2026 S | 702.770 | 0 | 5 | $-743.720 |
| Prakash Raman | Direktur | 18 Juni 2026 A | · | 0 | 0 | $0 |
| Hrustanovic Gorjan | Direktur | 18 Juni 2026 A | · | 0 | 0 | $0 |
| Yi Larson | Direktur | 18 Juni 2026 A | · | 0 | 0 | $0 |
| Graham Walmsley | Direktur | 18 Juni 2026 A | 700.761 | 0 | 0 | $0 |
| Sandra Horning | Direktur | 18 Juni 2026 A | · | 0 | 0 | $0 |
| Scott J. Garland | Direktur | 18 Juni 2026 A | · | 0 | 0 | $0 |
| Ian T Clark | Direktur | 18 Juni 2026 A | 0 | 0 | 3 | $-7.873.109 |
| Cynthia M Butitta | Direktur | 18 Juni 2026 A | 83.876 | 0 | 0 | $0 |
| Andrew Rappaport | Direktur | 18 Juni 2026 A | 0 | 0 | 0 | $0 |
| Frank Mccormick | Direktur | 23 Nov. 2020 C | 84.260 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Pemilik 10% | 23 Nov. 2020 C | 1.725.406 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 33 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,78% | 31.490 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,21% | 92.322 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,20% | 265.667 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 180.516 SH | 19 Agu 2026 | Harian |
| PWS · Pacer Funds Trust | 0,06% | 1.261 NS | 31 Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,06% | 541.502 SH | 11 Sep. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 56.779 SH | 19 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 6.145 SH | 2 Okt. 2026 | Harian |
| FFSM · FIDELITY COVINGTON TRUST | 0,03% | 41.085 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 451.269 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,03% | 37.461 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 2.009.029 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 69.692 SH | 2 Okt. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,02% | 233.776 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 652.061 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14.261 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 157.394 SH | 19 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,01% | 8.630 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,01% | 124.208 SH | 11 Sep. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 24.851 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 186.331 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.955 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2.323 SH | 11 Sep. 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,00% | 8.460 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 21.603 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 79.879 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 17.563 SH | 10 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 16.063 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.611.290 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.103 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 608.966 SH | 11 Sep. 2026 | Harian |
| ISCB · iShares Trust | · | 2.951 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 8.558 SH | 11 Sep. 2026 | Harian |
OLMA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 18 analis
BELI
Target median
$38.00
+362,0%
6 33,3%
Beli Kuat
10 55,6%
Beli
2 11,1%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
10 analis · 2026-09-28Target rata-rata $36.50 +343,8%
← Di bawah semua target
Harga saat ini $8.22
Rendah$16.00
Rata-rata$36.50
Tinggi$59.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| OLMA | $2.03B | -13.4 | · | · | -39.4% | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| ACHV | · | -4.0 | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 10, 2026